Paper Details

  1. Home
  2. Paper Details

Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.

Author: LaopaiboonMalinee, LumbiganonPisake, MolBen Willem J, SangkomkamhangUssanee S

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Uterine fibroids are common growths in the uterus that can cause heavy bleeding, pressure, and pain. While progesterone-based medications are used for fibroids, their effectiveness is still being studied. Progesterone can be given by injection (depot medroxyprogesterone acetate, DMPA), which can either stimulate or inhibit fibroid growth. Progesterone-releasing intrauterine devices (IUS) reduce menstrual bleeding by thinning the uterine lining and may also shrink fibroids, but their effectiveness for fibroids needs more research.
Paper Details　
Original Abstract of the Article :
Uterine fibroids are the most common premenopausal benign uterine tumours. Fibroids can cause symptoms including heavy menstrual bleeding, pelvic pressure and pain. Progestogens can be administered by various routes. Intramuscular injection of depot medroxyprogesterone acetate (DMPA) has dual action...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD008994.pub2

データ提供：米国国立医学図書館（NLM）

Progestogens for Uterine Fibroids

This research explores the use of progestogens, both oral and intrauterine, for the treatment of uterine fibroids, a common condition affecting premenopausal women. The study reviews the evidence for the effectiveness of progestogens in reducing symptoms associated with uterine fibroids, including heavy menstrual bleeding and pelvic pain. The authors discuss the potential mechanisms of action of progestogens and highlight the need for further research to evaluate the effectiveness of progestogen-releasing intrauterine systems (IUS) specifically for treating uterine fibroids. The study emphasizes the importance of developing effective and safe treatment options for uterine fibroids.

Progestogens and Uterine Fibroids

The research suggests that progestogens may be a viable treatment option for uterine fibroids. While further research is needed to fully understand the effectiveness of IUS specifically for treating uterine fibroids, the study highlights the potential benefits of progestogens in reducing symptoms associated with this condition. The study encourages further research to evaluate the long-term efficacy and safety of progestogens for the management of uterine fibroids. The research, like a well-planned expedition across a diverse landscape, aims to understand the complex nature of uterine fibroids and find effective solutions for managing this condition.

Managing Uterine Fibroids

This research provides valuable insights into the management of uterine fibroids. The study highlights the potential benefits of progestogens, both oral and intrauterine, in reducing symptoms associated with this condition. The study emphasizes the importance of continued research to determine the most effective and safe treatment options for uterine fibroids. The research, like a desert oasis providing sustenance and relief, offers hope for women seeking effective management of this common condition.

Dr.Camel's Conclusion

The researchers, like desert explorers seeking a hidden spring, are exploring the use of progestogens for treating uterine fibroids. Their study highlights the potential of these hormones in reducing symptoms associated with this condition, offering hope for women seeking effective management. The study underscores the importance of continued research and personalized approaches to optimize the use of progestogens, just as a camel must adapt to its environment to thrive in the desert.

Date :
  1. Date Completed 2013-03-28
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

23450594

DOI: Digital Object Identifier

10.1002/14651858.CD008994.pub2

Related Literature

Article Analysis
・Effective treatment of uterine fibroids
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.